Conceptus, Inc. (CPTS) Wins Favorable Verdict in Patent Litigation Against Hologic, Inc. (HOLX); Jury Awards Conceptus $18.8 Million
10/18/2011 9:47:44 AM
MOUNTAIN VIEW, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available, today announced that it has won a favorable jury verdict in its patent infringement lawsuit against Hologic, Inc. (Nasdaq:HOLX) in the United States District Court, Northern District of California. The jury has awarded Conceptus $18.8 million in monetary damages.
comments powered by